Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Cefixime and ceftriaxone susceptibility of Neisseria gonorrhoeae in Italy from 2006 to 2010
Cefixime-Induced Oculogyric Crisis
Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial
Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems
Cefminox, a Dual Agonist of Prostacyclin Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Identified by Virtual Screening, Has Therapeutic Efficacy against Hypoxia-Induced Pulmonary Hypertension in Rats
Cefoperazone-Sulbactam for Treatment of Intra-Abdominal Infections: Results from a Randomized, Parallel Group Study in India
Cefotaximase and AmpC-producing Shigella flexneri in case of dysentery from southern India
Cefotatan; A New Corrosion Inhibitor for Corrosion of Mild Steel in Hydrochloric Acid Solution
Ceforanide: a new and efficient corrosion inhibitor for mild steel in HCl solution
Cefoxitin is both an inhibitor of class A beta-lactamase of Xanthomonas campestris pv. campestris str. 17 and an inducer of its gene
Cefotaxime Resistant Escherichia coli Collected from a Healthy Volunteer; Characterisation and the Effect of Plasmid Loss
Cefoxitin Continuous Infusion for Lung Infection Caused by the Mycobacterium abscessus Group
Cefotaxime prevents microbial contamination and improves microspore embryogenesis in wheat and triticale
Cefotaxime-resistant Escherichia coli in broiler farms-A cross-sectional investigation in Germany
Cefozopran, meropenem, or imipenem-cilastatin compared with cefepime as empirical therapy in febrile neutropenic adult patients: A multicenter prospective randomized trial
Cefotetan versus Conventional Triple Antibiotic Prophylaxis in Elective Colorectal Cancer Surgery
Cefoperazone sodium preparation behavior after intramammary administration in healthy and infected cows
Cefoxitin Disc Test as a Marker for Detecting Methicillin Resistance in Staphylococcus aureus Isolates
Cefotaxime and Benzyladenine Improve Melon Regeneration
Cefotaxime-eluting covered self-expandable stents in a canine biliary model: scanning electron microscopic study of biofilm formation
Cefotaxime-Resistant Salmonella enterica in Travelers Returning from Thailand to Finland
Cefotaxime for the detection of extended-spectrum beta-lactamase or plasmid-mediated AmpC beta-lactamase and clinical characteristics of cefotaxime-non-susceptible Escherichia coli and Klebsiella pneumoniae bacteraemia
Cefoxitin as an Alternative to Carbapenems in a Murine Model of Urinary Tract Infection Due to Escherichia coli Harboring CTX-M-15-Type Extended-Spectrum beta-Lactamase
Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: Identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme
Cefotaxime and ceftazidime-resistant Escherichia coli isolate producing TEM-15 beta-lactamase from a Tunisian hospital
Cefovecin: A New Long-acting Cephalosporin
Cefotaxime-resistant E. coli in dairy and beef cattle farms-Joint analyses of two cross-sectional investigations in Germany
Cefoxitin as a carbapenem-sparing antibiotic for infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae
Cefoxitin Plasma and Subcutaneous Adipose Tissue Concentration in Patients Undergoing Sleeve Gastrectomy
Cefotaxime resistance and outcome of Klebsiella spp bloodstream infection
Cefoxitin and Ciprofloxacin Neurotoxicity and Catatonia in a Patient on Hemodialysis
Cefoxitin, second life?
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Cefpodoxime-Induced Hyperprolactinemic Galactorrhea
Cefpodoxime for Antimicrobial Prophylaxis in Neutropenia: A Retrospective Case Series
Cefpodoxime vs Ciprofloxacin for Short-Course Treatment of Acute Uncomplicated Cystitis A Randomized Trial
Cefpodoxime 10 mu g disc screening test for detection of Neisseria gonorrhoeae with mosaic PBP2 and decreased susceptibility to extended-spectrum cephalosporins for public health purposes
Cefquinome sulfate behavior after intramammary administration in healthy and infected cows
Cefquinome-loaded microsphere formulations against Klebsiella pneumonia infection during experimental infections
Cefquinome Controlled Size Submicron Particles Precipitation by SEDS Process Using Annular Gap Nozzle
Cefradine blocks solar-ultraviolet induced skin inflammation through direct inhibition of T-LAK cell-originated protein kinase
Ceftiofur attenuates lipopolysaccharide-induced acute lung injury
Ceftiofur impairs pro-inflammatory cytokine secretion through the inhibition of the activation of NF-kappa B and MAPK
Ceftiofur Regulates LPS-Induced Production of Cytokines and Improves LPS-Induced Survival Rate in Mice
Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B
Ceftriaxone-resistant Salmonella enterica serotype Newport, France
Ceftriaxone-induced hemolysis
Ceftriaxone and Acute Renal Failure in Children
Ceftaroline-Heteroresistant Staphylococcus aureus
Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model
Ceftriaxone, a beta-lactam antibiotic, attenuates relapse-like ethanol-drinking behavior in alcohol-preferring rats
Ceftobiprole Activity against over 60,000 Clinical Bacterial Pathogens Isolated in Europe, Turkey, and Israel from 2005 to 2010
Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model (vol 57, pg 66, 2013)
Ceftazidime-avibactam and comparator agents tested against urinary tract isolates from a global surveillance program (2011)
Ceftriaxone Treatment Affects the Levels of GLT1 and ENT1 As Well As Ethanol Intake in Alcohol-Preferring Rats
Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: Case series and review of the literature
Ceftaroline-Induced Eosinophilic Pneumonia
Ceftaroline - a cause for neutropenia
Ceftriaxone Preserves Glutamate Transporters and Prevents Intermittent Hypoxia-Induced Vulnerability to Brain Excitotoxic Injury
Ceftaroline plus Avibactam Demonstrates Bactericidal Activity against Pathogenic Anaerobic Bacteria in a One-Compartment In Vitro Pharmacokinetic/Pharmacodynamic Model
Ceftriaxone Treatment after Traumatic Brain Injury Restores Expression of the Glutamate Transporter, GLT-1, Reduces Regional Gliosis, and Reduces Post-Traumatic Seizures in the Rat
Ceftaroline Restores Daptomycin Activity against Daptomycin-Nonsusceptible Vancomycin-Resistant Enterococcus faecium
Ceftriaxone attenuates locomotor activity induced by acute and repeated cocaine exposure in mice
Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model
Ceftolozane/Tazobactam: A Novel Cephalosporin/beta-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli
Ceftobiprole medocaril is an effective treatment against methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis in a rat model
Ceftaroline-An Anti-MRSA Cephalosporin and Its Implications for Singapore
Ceftriaxone, ofloxacin and ciprofloxacin: An increased risk of bacterial resistance?
Ceftazidime-Avibactam: a Novel Cephalosporin/beta-lactamase Inhibitor Combination
Ceftriaxone-induced Biliary Sludge in a Patient with Uncontrolled Diabetes
Ceftaroline fosamil use in hospitalized patients with acute bacterial skin and skin structure infections: Budget impact analysis from a hospital perspective
Ceftaroline-Fosamil Efficacy against Methicillin-Resistant Staphylococcus aureus in a Rabbit Prosthetic Joint Infection Model
Ceftriaxone, a Beta-Lactam Antibiotic, Modulates Apoptosis Pathways and Oxidative Stress in a Rat Model of Neuropathic Pain
Ceftazidime-susceptible and imipenem-non-susceptible OXA-58-producing Acinetobacter baumannii from the Comoros archipelago
Ceftriaxone Blocks the Polymerization of alpha-Synuclein and Exerts Neuroprotective Effects in Vitro
Ceftriaxone modulates uptake activity of glial glutamate transporter-1 against global brain ischemia in rats
Ceftriaxone Protects Astrocytes from MPP+ via Suppression of NF-kappa B/JNK/c-Jun Signaling
Ceftriaxone attenuates cocaine relapse after abstinence through modulation of nucleus accumbens AMPA subunit expression
Ceftazidime-Avibactam: A Novel Cephalosporin/beta-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms
Ceftazidime pentahydrate/avibactam sodium, Isavuconazonium sulfate, and Daclatasvir dihydrochloride
Ceftobiprole medocaril in the treatment of hospital-acquired pneumonia
Ceftriaxone prevents and reverses behavioral and neuronal deficits in an MPTP-induced animal model of Parkinson's disease dementia
Ceftaroline activity on certain respiratory tract and wound infection agents at the minimum inhibitory concentration level
Ceftibuten-induced filamentation of extended spectrum beta lactamase (ESBL)-producing uropathogenic Escherichia coli alters host cell responses during an in vitro infection
Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience